CoChat

Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990–2013

Open access
Granich, Reuben, Gupta, Somya, Hersh, Bradley, Williams, Brian, Montaner, Julio, Young, Benjamin, Zuniga, José M. · 2015 · PLOS ONE
Cited by 167

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Antiretroviral therapy (ART) prevents human immunodeficiency virus (HIV) disease progression, mortality and transmission. We assess the impact of expanded HIV treatment for the prevention of Acquired Immunodeficiency Syndrome (AIDS)-related deaths and simulate four treatment scenarios for Nigeria and South Africa. METHODS: For 1990-2013, we used the Joint United Nations Programme on HIV/AIDS (UNAIDS) database to examine trends in AIDS deaths, HIV incidence and prevalence, ART coverage, annual AIDS death rate, AIDS death-to-treatment and HIV infections to treatment ratios for the top 30 countries with the highest AIDS mortality burden and compare them with data from high-income countries. We projected the 1990-2020 AIDS deaths for Nigeria and South Africa using four treatment scenarios: 1) no ART; 2) maintaining current ART coverage; 3) 90% ART coverage based on 2013 World Health Organization (WHO) ART guidelines by 2020; and 4) reaching the United Nations 90-90-90 Target by 2020. FINDINGS: In 2013, there were 1.3 million (1.1 million-1.6 million) AIDS deaths in the top 30 countries representing 87% of global AIDS deaths. Eight countries accounted for 58% of the global AIDS deaths; Nigeria and South Africa accounted for 27% of global AIDS deaths. The highest death rates per 1000 people living with HIV were in Central African Republic (91), South Sudan (82), Côte d'Ivoire (75), Cameroon (72) and Chad (71), nearly 8-10 times higher than the high-income countries. ART access in 2013 has averted as estimated 1,051,354 and 422,448 deaths in South Africa and Nigeria, respectively. Increasing ART coverage in these two countries to meet the proposed UN 90-90-90 Target by 2020 could avert 2.2 and 1.2 million deaths, respectively. INTERPRETATION: Over the past decade the expansion of access to ART averted millions of deaths. Reaching the proposed UN 90-90-90 Target by 2020 will prevent additional morbidity, mortality and HIV transmission. Despite progress, high-burden countries will need to accelerate access to ART treatment to avert millions of premature AIDS deaths and new HIV infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0131353

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. (2014) Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis. · DOI · Paper page
  2. AB Suthar, 2012, Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis, PLoS Med, 9, e1001270, 10.1371/journal.pmed.1001270 · DOI · Paper page
  3. F Tanser, 2013, High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa, Science, 339, 966, 10.1126/science.1228160 · DOI · Paper page
  4. JS Montaner, 2014, Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting, PLoS One, 9, e87872, 10.1371/journal.pone.0087872 · DOI · Paper page
  5. RM Granich, 2009, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model, Lancet, 373, 48, 10.1016/S0140-6736(08)61697-9 · DOI · Paper page
  6. JS Montaner, 2006, The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic, Lancet, 368, 531, 10.1016/S0140-6736(06)69162-9 · DOI · Paper page
  7. UNAIDS. The Last Climb: Ending AIDS, Leaving No One Behind. Executive Director Michel Sidibe speech, 20th International AIDS Conference Opening Session. Melbourne, Australia, July 2014. Available: http://www.unaids.org/sites/default/files/media_asset/20140720_SP_EXD_AIDS2014opening_en.pdf.
  8. J Stover, 2012, Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children, Sex Transm Infect, 88, i11, 10.1136/sextrans-2012-050640 · DOI
  9. V Miller, 2014, Beneficial impact of antiretroviral therapy on non-AIDS mortality, AIDS, 28, 273, 10.1097/QAD.0000000000000079 · DOI
  10. R Granich, 2012, Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011–2050, PLoS One, 7, e30216, 10.1371/journal.pone.0030216 · DOI · Paper page
  11. H Thirumurthy, 2013, Improved employment and education outcomes in households of HIV-infected adults with high CD4 cell counts: evidence from a community health campaign in Uganda, AIDS, 27, 627, 10.1097/QAD.0b013e32835c54d8 · DOI
  12. J Bor, 2012, In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment, Health Aff (Millwood), 31, 1459, 10.1377/hlthaff.2012.0407 · DOI · Paper page
  13. J Bor, 2013, Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment, Science, 339, 961, 10.1126/science.1230413 · DOI · Paper page
  14. S Lodi, 2011, Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm(3): assessment of need following changes in treatment guidelines, Clin Infect Dis, 53, 817, 10.1093/cid/cir494 · DOI · Paper page
  15. R Stoneburner, 2014, Using health surveillance systems data to assess the impact of AIDS and antiretroviral treatment on adult morbidity and mortality in Botswana, PLoS One, 9, e100431, 10.1371/journal.pone.0100431 · DOI
  16. AR May RM, 1988, The transmission dynamics of human immunodeficiency virus (HIV), Philos Trans R Soc Lond B Biol Sci, 321, 565, 10.1098/rstb.1988.0108 · DOI · Paper page
  17. Williams B, Gouws E. R0 and the elimination of HIV in Africa: Will 90-90-90 be sufficient? Available: http://arxiv.org/abs/1304.3720. · arXiv
  18. LF Johnson, 2012, The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis, Pediatr Infect Dis J, 31, 474, 10.1097/INF.0b013e3182456ba2 · doi:10.1097/inf.0b013e3182456ba2
  19. Gupta S, Williams B, Montaner J (2014) Realizing the Potential of Treatment as Prevention: Global ART Policy and Treatment Coverage. Curr HIV/AIDS Rep. · doi:10.1007/s11904-014-0230-z
  20. CJ Smith, 2014, Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration, Lancet, 384, 241, 10.1016/S0140-6736(14)60604-8 · DOI · Paper page
  21. CJ Murray, 2014, Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet, 384, 1005, 10.1016/S0140-6736(14)60844-8 · DOI · Paper page
  22. Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011 The Southern African Journal of HIV Medicine, March 2012. · DOI · Paper page
  23. B Houle, 2014, The unfolding counter-transition in rural South Africa: mortality and cause of death, 1994–2009, PLoS One, 9, e100420, 10.1371/journal.pone.0100420 · DOI
  24. ML Becker, 2012, Rates and determinants of HIV-attributable mortality among rural female sex workers in Northern Karnataka, India, Int J STD AIDS, 23, 36, 10.1258/ijsa.2011.011017 · DOI
  25. H Yan, 2014, Emerging disparity in HIV/AIDS disease progression and mortality for men who have sex with men, Jiangsu Province, China, AIDS Behav, 18, S5, 10.1007/s10461-013-0520-2 · doi:10.1007/s10461-013-0520-2
  26. SM Ingle, 2014, Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients, Clin Infect Dis, 59, 287, 10.1093/cid/ciu261 · DOI
  27. A Ciaranello, 2014, Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) east Africa regional analysis, Pediatr Infect Dis J, 33, 623, 10.1097/INF.0000000000000223 · doi:10.1097/inf.0000000000000223

Cited by

See all 167

Metadata

Authors
Granich, R., Gupta, S., Hersh, B., Williams, B., Montaner, J., Young, B., & Zuniga, J. M.
Venue
PLOS ONE
Published
2015-07-06
Volume
10
Issue
7
Pages
e0131353
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1809225310
Cited by
167
References
2
FWCI
12.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.